Response of malignant hypertension with refractory cardiac failure to captopril: A case report

A convincing response to the orally administered angiotensin I-converting enzyme inhibitor captopril (SQ 14225) in a severe hyper-reninaemic hypertensive patient resistant to other forms of treatment is described. The use of this drug in accelerated severe hypertension with impending organ damage is suggested during the early phase of treatment.